English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 862456      Online Users : 535
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/7649


    Title: Association between recent use of fluoroquinolones and rhegmatogenous retinal detachment: A population-based cohort study
    Authors: Kuo, SC;Chen, YT;Lee, YT;Fan, NW;Chen, SJ;Li, SY;Liu, CJ;Chen, TL;Chen, TJ;Fung, CP
    Contributors: Division of Infectious Diseases
    Abstract: Background: An association between use of oral fluoroquinolones (FQs) and retinal detachment remains controversial. This study was to determine the association of recent use of oral FQs and rhegmatogenous retinal detachment (RRD) after adjustment for confounding factors known to be associated with RRD.Methods:This retrospective population-based cohort study with parallel groups included adults treated with an oral FQ (FQ cohort 178 179 prescriptions) and propensity-score–matched adults treated with oral amoxicillin (amoxicillin cohort 178 179 prescriptions). The data were extracted from the Taiwan National Health Insurance Research Database from 1998 to 2010. Interaction terms were used to identify populations at risk. RRD was defined according to the International Classification of Disease, ninth revision.Results:During the 90-day follow-up period, 96 patients (0.054%) in the FQ cohort developed RRD compared to 46 (0.026%) among the matched amoxicillin cohort. The overall adjusted hazard ratio (aHR) for FQ use and RRD was 2.07 (95% confidence interval [CI], 1.45-2.96). The interval between use of oral FQs and onset of RRD was 35.5 days (interquartile range, 14-57). Interaction terms were not significant for age, sex, diabetes, indications for antimicrobials and underlying ophthalmic conditions. The aHRs differed for specific FQs. These were ciprofloxacin 10.68 (95% CI, 3.28-34.82), levofloxacin 2.41 (0.76-7.68), norfloxacin 2.00 (1.06-3.79), and ofloxacin 1.17 (0.59-2.31).Conclusions:The use of oral FQs was associated with the subsequent occurrence of RRD. The FQ risk was independent of age, sex, diabetes, indications for antimicrobials, or underlying ophthalmic conditions. Certain FQs carried higher risk of RRD.
    Date: 2014-01
    Relation: Clinical Infectious Diseases. 2014 Jan;58(2):197-203.
    Link to: http://dx.doi.org/10.1093/cid/cit708
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1058-4838&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000329131300011
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84891792341
    Appears in Collections:[郭書辰] 期刊論文

    Files in This Item:

    File Description SizeFormat
    PB2013112601.pdf236KbAdobe PDF455View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback